Back to search
FDAFDA · Food and drugs·Recall number D-0772-2021

Atovaquone Oral Suspension, USP, 750 mg/5 mL, 210 mL bottle, Rx Only, Mfd. By: KVK-Tech, Inc., Newtown, PA 18940, NDC 10702-223-21.

Published September 1, 2021 · Recall initiated: July 2, 2021

Summary

FDA records drug Class I recall D-0772-2021, published September 1, 2021 and initiated July 2, 2021. Recalling firm: KVK-Tech, Inc.; Status: Terminated; Reported quantity: 1,692 bottles; Lot: Batch # 16653A, 16654A, Exp 12/2022. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Temperature abuse: the firm received customer complaints of unusual grittiness in the product.

What to do

Voluntary: Firm initiated · Letter

Get an email if ATOVAQUONE ORAL SUSPENSION has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
ATOVAQUONE ORAL SUSPENSION
Manufacturer
KVK-Tech, Inc.
Distributor
Product was distributed to one distributor who may have further distributed Nationwide in the USA.
UPC
0310702223219
Lot
Batch # 16653A, 16654A, Exp 12/2022
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Atovaquone Oral Suspension, USP, 750 mg/5 mL, 210 mL bottle, Rx Only, Mfd. By: KVK-Tech, Inc., Newtown, PA 18940, NDC 10702-223-21. recalled?

Yes. FDA published recall D-0772-2021 on September 1, 2021. Reported hazard: Temperature abuse: the firm received customer complaints of unusual grittiness in the product.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: ATOVAQUONE ORAL SUSPENSION. UPC: 0310702223219.